|
Name |
3,4-diphenyl-5H-furan-2-one
|
| Molecular Formula | C16H12O2 | |
| IUPAC Name* |
3,4-diphenyl-2H-furan-5-one
|
|
| SMILES |
C1C(=C(C(=O)O1)C2=CC=CC=C2)C3=CC=CC=C3
|
|
| InChI |
InChI=1S/C16H12O2/c17-16-15(13-9-5-2-6-10-13)14(11-18-16)12-7-3-1-4-8-12/h1-10H,11H2
|
|
| InChIKey |
CPBAHTZRJQATEJ-UHFFFAOYSA-N
|
|
| Synonyms |
3,4-diphenyl-5H-furan-2-one; 5635-16-5; 3,4-Diphenylfuran-2(5H)-one; 3,4-diphenyl-2H-furan-5-one; 3,4-diphenyl-2,5-dihydrofuran-2-one; 3,4-diphenyl-2(5H)-furanone; CHEMBL1470821; NSC400730; Oprea1_147483; MLS001176843; SCHEMBL5071823; 2,3-diphenyl-2-buten-4-olide; DTXSID20322231; 3,4-diphenyl-2-(5H)-furanone; HMS2924F08; 3,4-diphenyl-2-(5H )-furanone; ZINC1593509; BDBM50033276; AKOS000117101; NSC-400730; SMR000591842; CS-0220371; EN300-06503; Z56943516
|
|
| CAS | 5635-16-5 | |
| PubChem CID | 344049 | |
| ChEMBL ID | CHEMBL1470821 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 236.26 | ALogp: | 3.0 |
| HBD: | 0 | HBA: | 2 |
| Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 26.3 | Aromatic Rings: | 3 |
| Heavy Atoms: | 18 | QED Weighted: | 0.738 |
| Caco-2 Permeability: | -4.615 | MDCK Permeability: | 0.00002470 |
| Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.002 |
| Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.598 |
| 30% Bioavailability (F30%): | 0.005 |
| Blood-Brain-Barrier Penetration (BBB): | 0.167 | Plasma Protein Binding (PPB): | 99.70% |
| Volume Distribution (VD): | 0.659 | Fu: | 1.02% |
| CYP1A2-inhibitor: | 0.981 | CYP1A2-substrate: | 0.111 |
| CYP2C19-inhibitor: | 0.521 | CYP2C19-substrate: | 0.055 |
| CYP2C9-inhibitor: | 0.387 | CYP2C9-substrate: | 0.783 |
| CYP2D6-inhibitor: | 0.082 | CYP2D6-substrate: | 0.473 |
| CYP3A4-inhibitor: | 0.105 | CYP3A4-substrate: | 0.163 |
| Clearance (CL): | 9.112 | Half-life (T1/2): | 0.341 |
| hERG Blockers: | 0.014 | Human Hepatotoxicity (H-HT): | 0.076 |
| Drug-inuced Liver Injury (DILI): | 0.963 | AMES Toxicity: | 0.012 |
| Rat Oral Acute Toxicity: | 0.36 | Maximum Recommended Daily Dose: | 0.022 |
| Skin Sensitization: | 0.083 | Carcinogencity: | 0.095 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.214 |
| Respiratory Toxicity: | 0.16 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC003032 | ![]() |
0.521 | D05VLS | ![]() |
0.620 | ||
| ENC004517 | ![]() |
0.494 | D0M9DC | ![]() |
0.500 | ||
| ENC004519 | ![]() |
0.494 | D0E4DW | ![]() |
0.421 | ||
| ENC004518 | ![]() |
0.494 | D08FTG | ![]() |
0.417 | ||
| ENC000321 | ![]() |
0.482 | D0B1FE | ![]() |
0.408 | ||
| ENC003342 | ![]() |
0.458 | D0G1VX | ![]() |
0.408 | ||
| ENC000732 | ![]() |
0.449 | D09VXM | ![]() |
0.395 | ||
| ENC000093 | ![]() |
0.446 | D04DXN | ![]() |
0.382 | ||
| ENC001109 | ![]() |
0.440 | D0QV5T | ![]() |
0.378 | ||
| ENC003697 | ![]() |
0.427 | D0Y7EM | ![]() |
0.375 | ||